VF
SXTP icon

Virtu Financial’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Virtu Financial’s Portfolio SXTP Stock Details SXTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-634
Closed -$16K – 2040
2024
Q3 		$16K Buy
634
+446
+237% +$16.5K ﹤0.01% 1152
2024
Q2 		$11K Sell
188
-60
-24% -$3.81K ﹤0.01% 1123
2024
Q1 		$16K Buy
+248
New +$27.7K ﹤0.01% 1199
2023
Q4 		– Sell
-60
Closed -$11K – 1984
2023
Q3 		$11K Buy
+60
New +$24.9K ﹤0.01% 1098

Other funds holding SXTP

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's SXTP Position: Q4 2024 in Review

Virtu Financial sold out of 60 Degrees Pharmaceuticals (SXTP) in Q4 2024, closing a stake of 634 shares — an estimated $16K sold.

Virtu Financial first reported a position in SXTP in Q3 2023 and held it in 4 quarters. The position peaked at $16K in Q3 2024. 9 funds tracked by Wall St. Rank hold SXTP as of Q4 2024.

  • Virtu Financial reported no remaining 60 Degrees Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 634 60 Degrees Pharmaceuticals shares in Q4 2024, an estimated $16K.
  • Virtu Financial first reported a position in 60 Degrees Pharmaceuticals in Q3 2023 and held it in 4 quarters.
  • Virtu Financial's 60 Degrees Pharmaceuticals position peaked at $16K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.